Arch Biopartners Inc (ACHFF)
1.29
-0.01
(-0.77%)
USD |
OTCM |
May 03, 16:00
Arch Biopartners Market Cap: 80.95M for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 80.95M |
| May 02, 2024 | 81.58M |
| May 01, 2024 | 80.33M |
| April 30, 2024 | 80.95M |
| April 29, 2024 | 84.78M |
| April 26, 2024 | 88.23M |
| April 25, 2024 | 94.13M |
| April 24, 2024 | 97.27M |
| April 23, 2024 | 101.66M |
| April 22, 2024 | 106.37M |
| April 19, 2024 | 108.57M |
| April 18, 2024 | 108.57M |
| April 17, 2024 | 107.94M |
| April 16, 2024 | 107.94M |
| April 15, 2024 | 106.68M |
| April 12, 2024 | 107.94M |
| April 11, 2024 | 108.57M |
| April 10, 2024 | 108.57M |
| April 09, 2024 | 111.08M |
| April 08, 2024 | 109.82M |
| April 05, 2024 | 109.82M |
| April 04, 2024 | 110.76M |
| April 03, 2024 | 111.08M |
| April 02, 2024 | 111.08M |
| April 01, 2024 | 107.31M |
| Date | Value |
|---|---|
| March 28, 2024 | 103.55M |
| March 27, 2024 | 102.29M |
| March 26, 2024 | 109.82M |
| March 25, 2024 | 112.58M |
| March 22, 2024 | 113.04M |
| March 21, 2024 | 113.59M |
| March 20, 2024 | 113.59M |
| March 19, 2024 | 109.82M |
| March 18, 2024 | 114.31M |
| March 15, 2024 | 100.41M |
| March 14, 2024 | 93.15M |
| March 13, 2024 | 87.23M |
| March 12, 2024 | 82.21M |
| March 11, 2024 | 81.58M |
| March 08, 2024 | 80.64M |
| March 07, 2024 | 79.70M |
| March 06, 2024 | 72.17M |
| March 05, 2024 | 71.95M |
| March 04, 2024 | 70.60M |
| March 01, 2024 | 69.66M |
| February 29, 2024 | 69.04M |
| February 28, 2024 | 69.16M |
| February 27, 2024 | 72.80M |
| February 26, 2024 | 70.91M |
| February 23, 2024 | 70.41M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
31.74M
Minimum
Mar 18 2020
234.97M
Maximum
Dec 06 2021
91.43M
Average
70.20M
Median
Nov 16 2020
Market Cap Benchmarks
| Acasti Pharma Inc | 27.82M |
| Aurinia Pharmaceuticals Inc | 729.40M |
| Edesa Biotech Inc | 14.69M |
| Lexaria Bioscience Corp | 40.33M |
| Xenon Pharmaceuticals Inc | 3.302B |
Market Cap Related Metrics
| PEG Ratio | -0.2087 |
| Price | 1.29 |
| Earnings Yield | -1.77% |
| PEGY Ratio | -0.2087 |